We have an unwavering commitment to improving care for patients with serious medical conditions through ongoing clinical development programs.
To learn more about clinical trials that are currently underway and to find out if a study is enrolling patients in your area or with your condition, please visit www.clinicaltrials.gov.
The results of certain applicable Jazz clinical trials are also available at www.clinicaltrials.gov.
As part of Jazz’s commitment to putting patients first, we are providing plain language summaries for certain clinical trials. These plain language summaries provide clinical trial results in an easy-to-understand format so all patients can obtain more information on the study results. Learn more about our study results.
This is a Phase 2/3 Clinical Study evaluating the investigational medication JZP-458 for the treatment for pediatric and adult patients with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived asparaginases. For more information, and to find out if a site is enrolling patients near you, please contact JZP458201@jazzpharma.com.
This is a Phase 3 Clinical Study evaluating an investigational medication for the treatment of idiopathic hypersomnia. For more information, and to find out if a site is enrolling patients near you, please email firstname.lastname@example.org or call 650-496-2951.
This page is for U.S. residents only. By clicking on this page, you confirm you are a U.S. resident.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.